These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36978159)

  • 1. Community data-driven approach to identify pathogenic founder variants for pan-ethnic carrier screening panels.
    Einhorn Y; Einhorn M; Kurolap A; Steinberg D; Mory A; Bazak L; Paperna T; Grinshpun-Cohen J; Basel-Salmon L; Weiss K; Singer A; Yaron Y; Baris Feldman H
    Hum Genomics; 2023 Mar; 17(1):30. PubMed ID: 36978159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pan-ethnic and ethnic-based carrier screening panels for individuals of Ashkenazi Jewish descent.
    Rosenblum LS; Zhu H; Zhou Z; Teicher J; Heim RA; Leach NT
    J Genet Couns; 2020 Feb; 29(1):56-66. PubMed ID: 31663226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic variant-based preconception carrier screening in the Israeli Jewish population.
    Davidov B; Levon A; Volkov H; Orenstein N; Karo R; Fatal Gazit I; Magal N; Basel-Salmon L; Golan Mashiach M
    Clin Genet; 2022 May; 101(5-6):517-529. PubMed ID: 35315053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; Astbury C; Cutting GR; Del Gaudio D; Gregg AR; Grody WW; Monaghan KG; Richards S;
    Genet Med; 2020 Aug; 22(8):1288-1295. PubMed ID: 32404922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
    Holtkamp KC; van Maarle MC; Schouten MJ; Dondorp WJ; Lakeman P; Henneman L
    Eur J Hum Genet; 2016 Feb; 24(2):171-7. PubMed ID: 25966636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
    Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
    J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rigorous approach for selection of optimal variant sets for carrier screening with demonstration of clinical utility.
    Perreault-Micale C; Davie J; Breton B; Hallam S; Greger V
    Mol Genet Genomic Med; 2015 Jul; 3(4):363-73. PubMed ID: 26247052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
    Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guidelines-consistent carrier screening panel that supports equity across diverse populations.
    Johansen Taber K; Ben-Shachar R; Torres R; Arjunan A; Muzzey D; Kaseniit KE; Goldberg J; Brown H
    Genet Med; 2022 Jan; 24(1):201-213. PubMed ID: 34906503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier screening in the Mexican Jewish community using a pan-ethnic expanded carrier screening NGS panel.
    Morgenstern-Kaplan D; Raijman-Policar J; Majzner-Aronovich S; Aradhya S; Pineda-Alvarez DE; Aguinaga M; García-Vences EE
    Genet Med; 2022 Apr; 24(4):821-830. PubMed ID: 34961661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.
    Park JS; Nam EJ; Park HS; Han JW; Lee JY; Kim J; Kim TI; Lee ST
    Cancer Res Treat; 2017 Oct; 49(4):1012-1021. PubMed ID: 28111427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier frequency of autosomal recessive genetic conditions in diverse populations: Lessons learned from the genome aggregation database.
    Schmitz MJ; Aarabi M; Bashar A; Rajkovic A; Gregg AR; Yatsenko SA
    Clin Genet; 2022 Aug; 102(2):87-97. PubMed ID: 35532184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
    Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
    BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of pathogenic variants in clinically actionable genes in a founder population.
    Lynch MT; Maloney KA; Pollin TI; Streeten EA; Xu H; ; Shuldiner AR; Van Hout CV; Gonzaga-Jauregui C; Mitchell BD
    Am J Med Genet A; 2021 Nov; 185(11):3476-3484. PubMed ID: 34467620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.
    Chetruengchai W; Shotelersuk V
    J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Israeli National Genetic database: a 10-year experience.
    Zlotogora J; Patrinos GP
    Hum Genomics; 2017 Mar; 11(1):5. PubMed ID: 28302154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders.
    Gonzalez-Mantilla AJ; Moreno-De-Luca A; Ledbetter DH; Martin CL
    JAMA Psychiatry; 2016 Mar; 73(3):275-83. PubMed ID: 26817790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG).
    Gregg AR; Aarabi M; Klugman S; Leach NT; Bashford MT; Goldwaser T; Chen E; Sparks TN; Reddi HV; Rajkovic A; Dungan JS;
    Genet Med; 2021 Oct; 23(10):1793-1806. PubMed ID: 34285390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.